Differential cellular effects of sunitinib and pazopanib targeted drugs for metastatic renal cell carcinoma

an in vitro approach

Autores

  • Filipa Amaro Associate Laboratory i4HB, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal. UCIBIO-REQUIMTE, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal.
  • Carolina Pisoeiro Associate Laboratory i4HB, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal. UCIBIO-REQUIMTE, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal.
  • Maria João Valente National Food Institute, Technical University of Denmark, Kongens Lyngby, Copenhagen, Denmark
  • Vera Miranda-Gonçalves Cancer Biology & Epigenetics Group–Research Centre, Portuguese Oncology Institute of Porto, Porto, Portugal.
  • Carmen Jerónimo Cancer Biology & Epigenetics Group–Research Centre, Portuguese Oncology Institute of Porto, Porto, Portugal. Department of Pathology, Portuguese Oncology Institute of Porto, Porto, Portugal.
  • Rui Henrique Cancer Biology & Epigenetics Group–Research Centre, Portuguese Oncology Institute of Porto, Porto, Portugal. Department of Pathology, Portuguese Oncology Institute of Porto, Porto, Portugal. Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar–University of Porto, Porto, Portugal.
  • Maria de Lourdes Bastos Associate Laboratory i4HB, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal. UCIBIO-REQUIMTE, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal.
  • Paula Guedes de Pinho Associate Laboratory i4HB, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal. UCIBIO-REQUIMTE, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal.
  • Márcia Carvalho Associate Laboratory i4HB, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal. UCIBIO-REQUIMTE, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal. FP-I3ID, FP-BHS, University Fernando Pessoa, Porto, Portugal. Faculty of Health Sciences, Fernando Pessoa University, Porto, Portugal.
  • Joana Pinto Associate Laboratory i4HB, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal. UCIBIO-REQUIMTE, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal.

DOI:

https://doi.org/10.51126/revsalus.v4iSup.401

Palavras-chave:

renal cell carcinoma, tyrosine kinase inhibitors, antiproliferative, cytotoxicity, in vitro

Downloads

Os dados de download ainda não estão disponíveis.

Downloads

Publicado

2022-04-06

Edição

Vol. 4 N.º Sup (2022): Suplemento da RevSALUS - Revista Científica Internacional da RACS

Secção

Pósteres

Licença

Creative Commons License

Este trabalho encontra-se publicado com a Licença Internacional Creative Commons Atribuição-NãoComercial-SemDerivações 4.0.

You are free to:
Share — copy and redistribute the material in any medium or format;
Adapt — remix, transform, and build upon the material for any purpose, even commercially.

Como Citar

Differential cellular effects of sunitinib and pazopanib targeted drugs for metastatic renal cell carcinoma: an in vitro approach. (2022). RevSALUS - Revista Científica Internacional Da Rede Académica Das Ciências Da Saúde Da Lusofonia, 4(Sup), 167-168. https://doi.org/10.51126/revsalus.v4iSup.401

Artigos mais lidos do(s) mesmo(s) autor(es)